Smallbatch adds goat and bison to freeze-dried treat line
Bottom line
Smallbatch Pets is expanding its freeze-dried, single-ingredient treat portfolio with three new products: Grass-fed Goat Hearts, Grass-fed Goat Livers, and Bison Livers, according to Pet Age’s report on the launch. The additions push the brand further into novel-protein treats, a segment aimed at pet parents seeking simpler ingredient decks and alternative proteins for dogs with food sensitivities or rotational-feeding routines. On its website, Smallbatch already positions its freeze-dried heart and liver treats as single-protein, limited-ingredient options for dogs and cats, and emphasizes sourcing, freeze-drying, and the absence of fillers or synthetic additives across the line. (petfoodindustry.com)
Why it matters: For veterinary professionals, the launch reflects continued consumer demand for limited-ingredient and novel-protein products, especially among pet parents managing suspected adverse food reactions or looking for high-value training treats that align with elimination-style feeding plans. But it also lands in a category that carries familiar counseling points: FDA says raw pet food, including frozen and freeze-dried products, is more likely than processed pet food to contain pathogens such as Salmonella and Listeria monocytogenes, and WSAVA notes that freezing, dehydration, or freeze-drying do not eliminate all risk. That means clinics may see more questions not just about ingredient selection, but about safe handling, household exposure, and whether these treats fit pets with immunocompromise, GI disease, or tightly controlled diet trials. (fda.gov)
What to watch: Watch for retail rollout details, possible expansion into additional novel proteins, and whether Smallbatch or trade partners provide more explicit guidance on handling and use cases for sensitive pets. (petsplusmag.com)
Smallbatch Pets is broadening its freeze-dried single-ingredient treat lineup with three new novel-protein products: Grass-fed Goat Hearts, Grass-fed Goat Livers, and Bison Livers. The move, first reported by Pet Age, extends the company’s presence in the fast-growing limited-ingredient treat segment, where brands are competing on simplicity, sourcing claims, and proteins positioned as alternatives to more common chicken or beef offerings. (petfoodindustry.com)
The expansion fits Smallbatch’s broader portfolio strategy. The company already sells freeze-dried heart and liver treats in more established proteins such as lamb, pork, beef, chicken, and turkey, while also marketing frozen raw, freeze-dried raw meals, and functional toppers built around single-protein positioning. On product pages, Smallbatch describes its treats as single-ingredient, freeze-dried, and free of fillers, grains, and synthetic additives, with heart products framed around taurine and protein, and liver products around vitamin A and mineral density. (smallbatchpets.com)
What changed here is the protein mix. Goat and bison are less common in mainstream treat assortments than chicken, beef, or pork, and that matters commercially because novel proteins are often marketed toward pet parents seeking more ingredient transparency or trying to avoid proteins they believe their dog has reacted to previously. Trade coverage of the broader category shows other companies also leaning into freeze-dried and limited-ingredient launches, suggesting Smallbatch is responding to a wider competitive push around minimally processed, protein-forward treats. (petfoodindustry.com)
I didn’t find independent veterinarian quotes reacting specifically to this Smallbatch launch. But expert guidance on the category is clear. Cornell’s Riney Canine Health Center notes that raw meat can also be sold as freeze-dried treats, and advises that high-risk people should not handle these products or contact dogs that consume them. FDA likewise says raw pet food, including freeze-dried products, can be contaminated with Salmonella or Listeria, and that pets may shed pathogens without appearing sick. WSAVA’s nutrition guidance adds that freeze-drying does not eliminate all pathogen risk. (vet.cornell.edu)
That risk discussion is especially relevant because the single-ingredient claim can create a “clean-label halo” for pet parents. Simpler labels may support diet history reviews and can be useful when selecting treats that won’t obviously undermine a nutrition plan. Still, single-ingredient does not mean complete and balanced, and in the case of organ-based treats, veterinarians may want to remind clients about portion control, calorie contribution, and the difference between a treat used occasionally and a diet component used daily. Clinics may also need to reinforce that pets on strict elimination trials generally need treats that match the prescribed protocol exactly, rather than simply any novel protein from the shelf. This is an inference based on standard nutritional management principles and the way these products are positioned. (smallbatchpets.com)
Why it matters: From an industry standpoint, this is another sign that treat innovation is moving beyond flavor variety into more specialized protein positioning. For veterinary teams, that likely means more client questions about whether goat or bison treats are appropriate for dogs with suspected food sensitivities, whether freeze-dried raw treats are safer than frozen raw, and how to balance palatability with infection-control concerns in the home. FDA’s guidance remains a useful anchor here: raw diets are more likely than processed pet foods to contain harmful bacteria, and safe handling matters for both animal and human health. (fda.gov)
There’s also a regulatory and reputational backdrop to keep in mind. FDA has documented recalls involving freeze-dried pet treats because of potential Salmonella contamination, underscoring that this category can face the same safety scrutiny as other raw-adjacent products. That does not mean these new Smallbatch treats have a known safety issue, only that veterinary professionals counseling pet parents on raw or freeze-dried products should discuss storage, hand hygiene, bowl cleaning, and household risk, particularly where children, older adults, pregnant people, or immunocompromised family members are present. (fda.gov)
What to watch: Next, watch for formal rollout details across distributors and independent pet retail, any additional novel-protein extensions in the Smallbatch treat line, and whether the company pairs the launch with clearer education around handling and use in sensitive-pet households. (petsplusmag.com)